Size: px
Start display at page:

Download ""

Transcription

1

2

3

4

5 µ µ µ µ

6 µ µ µ µ µ µ

7

8

9 γ

10

11

12 薏 芎

13

第86回日本感染症学会総会学術集会後抄録(I)

第86回日本感染症学会総会学術集会後抄録(I) κ κ κ κ κ κ μ μ β β β γ α α β β γ α β α α α γ α β β γ μ β β μ μ α ββ β β β β β β β β β β β β β β β β β β γ β μ μ μ μμ μ μ μ μ β β μ μ μ μ μ μ μ μ μ μ μ μ μ μ β

More information

O1-1 O1-2 O1-3 O1-4 O1-5 O1-6

O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-1 O1-2 O1-3 O1-4 O1-5 O1-6 O1-7 O1-8 O1-9 O1-10 O1-11 O1-12 O1-13 O1-14 O1-15 O1-16 O1-17 O1-18 O1-19 O1-20 O1-21 O1-22 O1-23 O1-24 O1-25 O1-26 O1-27 O1-28 O1-29 O1-30 O1-31 O1-32 O1-33 O1-34 O1-35

More information

概況

概況 2 4 6 2 2 2 3 2 4 22 5 23 27 34 37 44 45 46 2 78.67 85.77 2.6. 7. 2 2, 65 85,464 93,8 65 85.5 93.2 8 56.2 77.9 2 8.87 88.8 3 () 65 3 6 2 2 2 2 2 22 3 2 2 2 2 2 2 2 2 28.58 28.74 29.9 8.8 8.84 2.63 65 28.3

More information

研修コーナー

研修コーナー l l l l l l l l l l l α α β l µ l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l l

More information

-2-0.5 5 6 7 8 9 10 11 12 13 14 15 16 etc 17 22 11/15 12/17 2/28

-2-0.5 5 6 7 8 9 10 11 12 13 14 15 16 etc 17 22 11/15 12/17 2/28 -1-1-1 3 3 2 12 2 2 1 1-2 3 2 0.6 1-3 1 2 3 4 -2-0.5 5 6 7 8 9 10 11 12 13 14 15 16 etc 17 22 11/15 12/17 2/28 -3-3/2 5/26 147 18 21 19 -4-20 21 22 23 24 25 26 27 28 29 30 31 1 1 1-1 芎 2 4 1 1-2 1 芎 7

More information

1 1 3 2 8g 芩 芩 1 7 5 2 2 1 7 芩 1 芎 1 2 1 2 1 8 蘞 7 120 40 20 1 10 1-2-

1 1 3 2 8g 芩 芩 1 7 5 2 2 1 7 芩 1 芎 1 2 1 2 1 8 蘞 7 120 40 20 1 10 1-2- 5 or 100 怔 忡 3 1 1 1 2 1 5 2 7 15 2 5 1 2 5 2 1 10 80 1 1 4 8 9 7 1 8 9 7 1 8 9 7 4 8 9 7 4 3-1- 1 1 3 2 8g 芩 芩 1 7 5 2 2 1 7 芩 1 芎 1 2 1 2 1 8 蘞 7 120 40 20 1 10 1-2- 2 2 1 7 5 2 1 2 1 7 5 2 1 30 1 芎

More information

nsg04-28/ky208684356100043077

nsg04-28/ky208684356100043077 δ!!! μ μ μ γ UBE3A Ube3a Ube3a δ !!!! α α α α α α α α α α μ μ α β α β β !!!!!!!! μ! Suncus murinus μ Ω! π μ Ω in vivo! μ μ μ!!! ! in situ! in vivo δ δ !!!!!!!!!! ! in vivo Orexin-Arch Orexin-Arch !!

More information

EPSON LP-8900ユーザーズガイド

EPSON LP-8900ユーザーズガイド 3 4 5 6 7 8 abc ade w p s 9 10 s s 11 p 12 p 13 14 p s 15 p s A B 16 w 17 C p 18 D E F 19 p w G H 20 A B 21 C s p D 22 E s p w 23 w w s 24 p w s 25 w 26 p p 27 w p s 28 w p 29 w p s 30 p s 31 A s B 32

More information

蔞 蔞 蔞 芎 芎 羗

蔞 蔞 蔞 芎 芎 羗 4.5 30 15 3 9 6 15 豉 芩 藿 芩 芎 8 5 1 2 3 10g 10g 10g 18g 3g 芩 2g 3 2g 7 2 1 2 2 5 1-1- 蔞 蔞 蔞 30 50 1-1 7 芎 5 5 3 2 1-2 5 3 芎 1 1 5 羗 5 30 50 1-1 3 3 3 6 12-2- -3-1-2 15g 9g 6g 9g 6g 1-3 3g 6g 240 80 3 1

More information

XV-Z10000(J)Ł\1-4.p65

XV-Z10000(J)Ł\1-4.p65 http://www.sharp.co.jp/ 4 2-JW age 2 2..5, :42 2 age 2 2..5, :44 3 age 3 2..5, :44 4 2..5, :44 age 4 5 2..5, :44 age 5 6 2..5, :44 age 6 7 2..5, :44 age 7 8 age 8 2..5, :45 75 76 9 age 9 2..5, :45 4 4

More information

nsg02-13/ky045059301600033210

nsg02-13/ky045059301600033210 φ φ φ φ κ κ α α μ μ α α μ χ et al Neurosci. Res. Trpv J Physiol μ μ α α α β in vivo β β β β β β β β in vitro β γ μ δ μδ δ δ α θ α θ α In Biomechanics at Micro- and Nanoscale Levels, Volume I W W v W

More information

N cos s s cos ψ e e e e 3 3 e e 3 e 3 e

N cos s s cos ψ e e e e 3 3 e e 3 e 3 e 3 3 5 5 5 3 3 7 5 33 5 33 9 5 8 > e > f U f U u u > u ue u e u ue u ue u e u e u u e u u e u N cos s s cos ψ e e e e 3 3 e e 3 e 3 e 3 > A A > A E A f A A f A [ ] f A A e > > A e[ ] > f A E A < < f ; >

More information

日歯雑誌(H28・8月号)別刷り/ポスターセッション とびら

日歯雑誌(H28・8月号)別刷り/ポスターセッション とびら α P. gingivalis P. gingivalis αsmatgf- VEGF-A α in vitro μ Porphyromonas gingivalis in vitro Porphyromonas gingivalis β β β JBiolChem. μ μ μ β Porphyromonas gingivalis in vitro μ α β α

More information

TEL-E7

TEL-E7 Ni-Cd TEL-E7 TEL-EW7 2 3 4 5 6 7 8 9 0 2 3 4 5 6 7 8 9 20 Ni-Cd 2 3 2 2 3 22 2 2 3 4 3 4 23 2 2 3 3 24 25 2 3 4 2 3 4 26 2 3 2 3 27 2 2 2 28 2 2 2 29 2 3 2 4 30 2 2 3 3 2 3 2 3 3 32 33 2 3 34 2 3 35

More information

内科96巻3号★/NAI3‐1(第22回試験問題)

内科96巻3号★/NAI3‐1(第22回試験問題) µ µ α µ µ µ µ µ µ β β α γ µ Enterococcus faecalis Escherichia coli Legionella pneumophila Pseudomonas aeruginosa Streptococcus viridans α β 正解表正解記号問題 No. 正解記号問題 No. e(4.5) 26 e 1 a(1.2) 27 a 2

More information

LLG-R8.Nisus.pdf

LLG-R8.Nisus.pdf d M d t = γ M H + α M d M d t M γ [ 1/ ( Oe sec) ] α γ γ = gµ B h g g µ B h / π γ g = γ = 1.76 10 [ 7 1/ ( Oe sec) ] α α = λ γ λ λ λ α γ α α H α = γ H ω ω H α α H K K H K / M 1 1 > 0 α 1 M > 0 γ α γ =

More information

g 4g

g 4g 1 2 40 50 2 1 7 3 3 9g 9g 9g 12g 12g 12g 12g 3g 1 30 1 芩 羗 7 5 3 1-1 -1- -2-1-2 2 2 4 6 2 1-3 2g 4g 3 6 1 9 11 2.0g 4.0g 3.0g 6.0g 1.0g 2 豉 1 5 1 5 茋 4 10 8 2 3 癥 1 1 7 5-3- -4- = 芎 5 2 3 1 芎 50 70 芩 12

More information

O x y z O ( O ) O (O ) 3 x y z O O x v t = t = 0 ( 1 ) O t = 0 c t r = ct P (x, y, z) r 2 = x 2 + y 2 + z 2 (t, x, y, z) (ct) 2 x 2 y 2 z 2 = 0

O x y z O ( O ) O (O ) 3 x y z O O x v t = t = 0 ( 1 ) O t = 0 c t r = ct P (x, y, z) r 2 = x 2 + y 2 + z 2 (t, x, y, z) (ct) 2 x 2 y 2 z 2 = 0 9 O y O ( O ) O (O ) 3 y O O v t = t = 0 ( ) O t = 0 t r = t P (, y, ) r = + y + (t,, y, ) (t) y = 0 () ( )O O t (t ) y = 0 () (t) y = (t ) y = 0 (3) O O v O O v O O O y y O O v P(, y,, t) t (, y,, t )

More information

10 : 3010 : 54 1F Annex 1! 1 15:3015 : 58 1F Annex 1

10 : 3010 : 54 1F Annex 1! 1 15:3015 : 58 1F Annex 1 4 16 1 10:0010 : 24 1F Annex 1! 2 15:0015 : 24 1F Annex 1!! 10 : 3010 : 54 1F Annex 1! 1 15:3015 : 58 1F Annex 1 ! 2 10:0010 : 28 1F Annex 1 3 15:0015 : 28 1F Annex 1 4 10:3010 : 58 1F Annex 1 1 15:3015

More information

NL10

NL10 Information September, 2006 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.10 September, 2006 3 2006 4 Japanese Association for Molecular Target Therapy of Cancer News Letter

More information

日本医科大学医学会雑誌第8巻第1号

日本医科大学医学会雑誌第8巻第1号 Xenopus laevis in situ μ μ Xenopus laevis Xenopus laevis Xenopus laevis UGT1A1 UGT1A1 IL28B KRAS UGT1A1 UGT1A128 UGT UGT1A1 UGT1A128 UGT1A1 286 UGT1A1 UGT1A1 28 6 UGT UGT UGT1A128 UGT IL28B UGT1A1

More information

CVMに基づくNi-Al合金の

CVMに基づくNi-Al合金の CV N-A (-' by T.Koyama ennard-jones fcc α, β, γ, δ β α γ δ = or α, β. γ, δ α β γ ( αβγ w = = k k k ( αβγ w = ( αβγ ( αβγ w = w = ( αβγ w = ( αβγ w = ( αβγ w = ( αβγ w = ( αβγ w = ( βγδ w = = k k k ( αγδ

More information

μ μ μ

μ μ μ TitleLC/MS 法を用いた局所麻酔薬の血中濃度測定 澤木, 康平 ; 大久保, みぎわ ; 四宮, 敬史 ; 塚越, 絵里 ; Author(s) 山﨑, 貴希 ; 劔持, 正浩 ; 宮尾, 真理子 ; 金子, 譲 ; 一 戸, 達也 ; 川口, 充 Journal 歯科学報, 110(3): 347-352 URL http://hdl.handle.net/10130/1699 Right

More information

original: 2011/11/5 revised: 2012/10/30, 2013/12/ : 2 V i V t2 V o V L V H V i V i V t1 V o V H V L V t1 V t2 1 Q 1 1 Q

original: 2011/11/5 revised: 2012/10/30, 2013/12/ : 2 V i V t2 V o V L V H V i V i V t1 V o V H V L V t1 V t2 1 Q 1 1 Q original: 2011/11/5 revised: 2012/10/30, 2013/12/2 1 1 1: 2 V i V t2 V o V L V H V i V i V t1 V o V H V L V t1 V t2 1 Q 1 1 Q 2 2 1 2 1 c 2013 2 2: V i Q 1 I C1 V C1 V B2 I E V E V E Q 1 Q 1 Q 2 Q 2 Q

More information

「スウェーデン企業におけるワーク・ライフ・バランス調査 」報告書

「スウェーデン企業におけるワーク・ライフ・バランス調査 」報告書 1 2004 12 2005 4 5 100 25 3 1 76 2 Demoskop 2 2004 11 24 30 7 2 10 1 2005 1 31 2 4 5 2 3-1-1 3-1-1 Micromediabanken 2005 1 507 1000 55.0 2 77 50 50 /CEO 36.3 37.4 18.1 3-2-1 43.0 34.4 / 17.6 3-2-2 78 79.4

More information

3/4/8:9 { } { } β β β α β α β β

3/4/8:9 { } { } β β β α β α β β α β : α β β α β α, [ ] [ ] V, [ ] α α β [ ] β 3/4/8:9 3/4/8:9 { } { } β β β α β α β β [] β [] β β β β α ( ( ( ( ( ( [ ] [ ] [ β ] [ α β β ] [ α ( β β ] [ α] [ ( β β ] [] α [ β β ] ( / α α [ β β ] [ ] 3

More information

NL11

NL11 information September, 2007 1 2 Japanese Association for Molecular Target Therapy of Cancer News Letter No.11 September, 2007 3 2007 4 Japanese Association for Molecular Target Therapy of Cancer News Letter

More information

untitled

untitled 9118 154 B-1 B-3 B- 5cm 3cm 5cm 3m18m5.4m.5m.66m1.3m 1.13m 1.134m 1.35m.665m 5 , 4 13 7 56 M 1586.1.18 7.77.9 599.5.8 7 1596.9.5 7.57.75 684.11.9 8.5 165..3 7.9 87.8.11 6.57. 166.6.16 7.57.6 856 6.6.5

More information

.\ /......

.\ /...... 教育 研究 社会貢献活動報告 香 川 医 科 大 学 平成1 3年度 香川医科大学自己点検評価委員会 γ α β β β α β β γ γ α β αβ µ Anopheles Bolbosoma Leishmania Pneumocystis carinii P. carinii Bolbosoma Leishmania Anopheles Plasmodium

More information

NISTEP REPORT No. 95 ( ) ( ) ( ) ( ) ( ) ( ) 104 397 1022 1050 1173 1674 1738 2679(651cites) 2683 2721 2763 2780 3032 3865 3866 3879 3928 4151 4203 4335 4676 4682 4699 4715 4898 5431

More information

zsj2017 (Toyama) program.pdf

zsj2017 (Toyama) program.pdf 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88

More information

88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88

More information

_170825_<52D5><7269><5B66><4F1A>_<6821><4E86><5F8C><4FEE><6B63>_<518A><5B50><4F53><FF08><5168><9801><FF09>.pdf

_170825_<52D5><7269><5B66><4F1A>_<6821><4E86><5F8C><4FEE><6B63>_<518A><5B50><4F53><FF08><5168><9801><FF09>.pdf 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88 th Annual Meeting of the Zoological Society of Japan Abstracts 88

More information

²�ËÜËܤǻþ·ÏÎó²òÀÏÊÙ¶¯²ñ - Â裱¾Ï¤ÈÂ裲¾ÏÁ°È¾

²�ËÜËܤǻþ·ÏÎó²òÀÏÊÙ¶¯²ñ - Â裱¾Ï¤ÈÂ裲¾ÏÁ°È¾ Kano Lab. Yuchi MATSUOKA December 22, 2016 1 / 32 1 1.1 1.2 1.3 1.4 2 ARMA 2.1 ARMA 2 / 32 1 1.1 1.2 1.3 1.4 2 ARMA 2.1 ARMA 3 / 32 1.1.1 - - - 4 / 32 1.1.2 - - - - - 5 / 32 1.1.3 y t µ t = E(y t ), V

More information

BayesfiI‡É“ÅfiK‡È−w‘K‡Ì‡½‡ß‡ÌChow-Liu…A…‰…S…−…Y…•

BayesfiI‡É“ÅfiK‡È−w‘K‡Ì‡½‡ß‡ÌChow-Liu…A…‰…S…−…Y…• 1 / 21 Kruscal V : w i,j R: w i,j = w j,i i j Kruscal (w i,j 0 ) 1 E {{i, j} i, j V, i i} 2 E {} 3 while(e = ϕ) for w i,j {i, j} E 1 E E\{i, j} 2 G = (V, E {i, j}) = E E {i, j} G {i,j} E w i,j 2 / 21 w

More information

_FH28_J.qxd

_FH28_J.qxd 23.9 + + ø ø ø ø ø ø ø ø ø ++ + ++ + + + ± FH 28 D - 5 (25) S B -.5 SH (5) 2 3 4 5 6 7 8 9 2 6 7 3 8 4 9 5 ** ** ** ** ** ** ** ** ** ** ** ** ** CL586-86-4-** CL586-868-3-** CL586-823-5-** CL586-835-4-**

More information

all.dvi

all.dvi 72 9 Hooke,,,. Hooke. 9.1 Hooke 1 Hooke. 1, 1 Hooke. σ, ε, Young. σ ε (9.1), Young. τ γ G τ Gγ (9.2) X 1, X 2. Poisson, Poisson ν. ν ε 22 (9.) ε 11 F F X 2 X 1 9.1: Poisson 9.1. Hooke 7 Young Poisson G

More information

2.7.6 MJR a MRI CT b 2 Beecham r-afs mg/ mg/ Gn-RH 742

2.7.6 MJR a MRI CT b 2 Beecham r-afs mg/ mg/ Gn-RH 742 MJR-35 34 1 1 a MRICT b 2Beecham r-afs 3 4 20 4 mg/ 20 40 5 6 2 1 2 3 44 mg/ 5 6 7 8 4 Gn-RH 742 9 10 11 12 1 20 60 1 1MJR-351 mg/ 0.25 2 Lot. No. 2MJR-352 mg/ 1 1 Lot. No. 3MJR-354 mg/ 1 2 Lot. No. 2

More information

1 2 Visual SLAM 2 Visual SLAM

1 2 Visual SLAM 2 Visual SLAM 00D8102006F 2004 3 1 2 Visual SLAM 2 Visual SLAM 1 1 2 2 2.1 2 2.2 2 2.3 2 3 4 3.1 4 3.2 Kedall 4 3.3 Poisso 5 3.4 M/M/c 6 4 12 4.1 12 4.2 13 4.3 16 4.4 Visual SLAM 20 4.4.1 Visual SLAM 20 4.4.2 20 4.4.3

More information

(I) (II) 2 (I) 2 (II) 2 (III) (I) (II) (II) : 2 Typeset by Akio Namba usig Powerdot. 2 / 47

(I) (II) 2 (I) 2 (II) 2 (III) (I) (II) (II) : 2 Typeset by Akio Namba usig Powerdot. 2 / 47 4 Typeset by Akio Namba usig Powerdot. / 47 (I) (II) 2 (I) 2 (II) 2 (III) (I) (II) (II) : 2 Typeset by Akio Namba usig Powerdot. 2 / 47 (I) (II) 2 (I) 2 (II) 2 (III) (I) (II) (II) : 2 (radom variable):

More information

研修コーナー

研修コーナー l l l l l l l Department of Obstetrics and Gynecology, Fukui Medical University, Fukui l l l l l l µ l β β l α l µ µ l l l l Department of Obstetrics and Gynecology, Gifu University School of Medicine,

More information

untitled

untitled ( 9:: 3:6: (k 3 45 k F m tan 45 k 45 k F m tan S S F m tan( 6.8k tan k F m ( + k tan 373 S S + Σ Σ 3 + Σ os( sin( + Σ sin( os( + sin( os( p z ( γ z + K pzdz γ + K γ K + γ + 9 ( 9 (+ sin( sin { 9 ( } 4

More information

Evolutes and involutes of fronts Masatomo Takahashi Muroran Institute of Technology

Evolutes and involutes of fronts Masatomo Takahashi Muroran Institute of Technology Evolutes and involutes of fronts Masatomo Takahashi Muroran Institute of Technology evolute involute, evolvent involute : involvo evolvent : evolvo 6 4 6 4 4 6 4 6 H 3 γ : I R C γ(t) 0, t(t) := γ(t) γ(t),

More information

Lecture 12. Properties of Expanders

Lecture 12. Properties of Expanders Lecture 12. Properties of Expanders M2 Mitsuru Kusumoto Kyoto University 2013/10/29 Preliminalies G = (V, E) L G : A G : 0 = λ 1 λ 2 λ n : L G ψ 1,..., ψ n : L G µ 1 µ 2 µ n : A G ϕ 1,..., ϕ n : A G (Lecture

More information

‚åŁÎ“·„´Šš‡ðŠp‡¢‡½‹âfi`fiI…A…‰…S…−…Y…•‡ÌMarkovŸA“½fiI›ð’Í

‚åŁÎ“·„´Šš‡ðŠp‡¢‡½‹âfi`fiI…A…‰…S…−…Y…•‡ÌMarkovŸA“½fiI›ð’Í Markov 2009 10 2 Markov 2009 10 2 1 / 25 1 (GA) 2 GA 3 4 Markov 2009 10 2 2 / 25 (GA) (GA) L ( 1) I := {0, 1} L f : I (0, ) M( 2) S := I M GA (GA) f (i) i I Markov 2009 10 2 3 / 25 (GA) ρ(i, j), i, j I

More information

根治的手術を施行し得た同時性重複癌 ( 進展舌癌と食道 Title 癌 ) の1 例 千葉, 哲彦 ; 岩本, 昌士 ; 齊藤, シオン ; 八木澤, 潤子 ; Author(s) 野本, 俊太郎 ; 市川, 秀樹 ; 成田, 真人 ; 伊藤, 亜希 ; 松崎, 英雄 ; 田中, 潤一 ; 髙野, 伸夫 Journal 歯科学報, 109(2): 192-200 URL http://hdl.handle.net/10130/912

More information

II (No.2) 2 4,.. (1) (cm) (2) (cm) , (

II (No.2) 2 4,.. (1) (cm) (2) (cm) , ( II (No.1) 1 x 1, x 2,..., x µ = 1 V = 1 k=1 x k (x k µ) 2 k=1 σ = V. V = σ 2 = 1 x 2 k µ 2 k=1 1 µ, V σ. (1) 4, 7, 3, 1, 9, 6 (2) 14, 17, 13, 11, 19, 16 (3) 12, 21, 9, 3, 27, 18 (4) 27.2, 29.3, 29.1, 26.0,

More information

2 羗 芩 芩 羗 5 2 螃 芩 螃 1 2 芩 葙 茺

2 羗 芩 芩 羗 5 2 螃 芩 螃 1 2 芩 葙 茺 2 1 2 1 5 3 70 2 1 5 剉 1 3 2 1 5 芩 艽 5 2 1 12g g 蓯 9g 5g2.5g 3g 蓯 -1- 2 羗 芩 1 5 2 芩 羗 5 2 螃 1 5 5 5 2 1 5 芩 螃 1 2 芩 1 1 5 3 1 1 葙 茺 7 5 1 2-2- -3-3 8 3 2 芩 4 3 3 2 1 -4-3g 剉 30g 9g 9g 60g 2 1-1 4 3 1 2

More information

- 1 - - 2 - - 3 - - 4 - - 5 - - 6 - 20log10 150 = 44 20log10 150 = 44-7 - - 8 - - 9 - - 10 - L ks X n + X 2 2 ) ( 1) ( 1 = X X n S n n n X L k k n X n X S n L n k - 11 - - 12 - - 13 - - 14 - - 15 - - 16

More information

D = [a, b] [c, d] D ij P ij (ξ ij, η ij ) f S(f,, {P ij }) S(f,, {P ij }) = = k m i=1 j=1 m n f(ξ ij, η ij )(x i x i 1 )(y j y j 1 ) = i=1 j

D = [a, b] [c, d] D ij P ij (ξ ij, η ij ) f S(f,, {P ij }) S(f,, {P ij }) = = k m i=1 j=1 m n f(ξ ij, η ij )(x i x i 1 )(y j y j 1 ) = i=1 j 6 6.. [, b] [, d] ij P ij ξ ij, η ij f Sf,, {P ij } Sf,, {P ij } k m i j m fξ ij, η ij i i j j i j i m i j k i i j j m i i j j k i i j j kb d {P ij } lim Sf,, {P ij} kb d f, k [, b] [, d] f, d kb d 6..

More information

0 ϕ ( ) (x) 0 ϕ (+) (x)ϕ d 3 ( ) (y) 0 pd 3 q (2π) 6 a p a qe ipx e iqy 0 2Ep 2Eq d 3 pd 3 q 0 (2π) 6 [a p, a q]e ipx e iqy 0 2Ep 2Eq d 3 pd 3 q (2π)

0 ϕ ( ) (x) 0 ϕ (+) (x)ϕ d 3 ( ) (y) 0 pd 3 q (2π) 6 a p a qe ipx e iqy 0 2Ep 2Eq d 3 pd 3 q 0 (2π) 6 [a p, a q]e ipx e iqy 0 2Ep 2Eq d 3 pd 3 q (2π) ( ) 2 S 3 ( ) ( ) 0 O 0 O ( ) O ϕ(x) ϕ (x) d 3 p (2π) 3 2Ep (a p e ipx + b pe +ipx ) ϕ (+) (x) + ϕ ( ) (x) d 3 p (2π) 3 2Ep (a pe +ipx + b p e ipx ) ϕ ( ) (x) + ϕ (+) (x) (px p 0 x 0 p x E p t p x, E p

More information

日医雑誌第126巻第9号

日医雑誌第126巻第9号 [] HIV 4 sexually transmitted diseases 1975 WHO 12 3 2 5 3 1 1 4 3 40 1 1947 4 WHO 1975 STDsexually transmitted diseases STIsexually transmitted infection 5 STD 5 10 20 5 5 HIV STD RTIreproductive tract

More information

Japan Research Review 1998年7月号

Japan Research Review 1998年7月号 Japan Research Review 1998.7 Perspectives ****************************************************************************************** - 1 - Japan Research Review 1998.7-2 - Japan Research Review 1998.7-3

More information

Γ Ec Γ V BIAS THBV3_0401JA THBV3_0402JAa THBV3_0402JAb 1000 800 600 400 50 % 25 % 200 100 80 60 40 20 10 8 6 4 10 % 2.5 % 0.5 % 0.25 % 2 1.0 0.8 0.6 0.4 0.2 0.1 200 300 400 500 600 700 800 1000 1200 14001600

More information

DVIOUT-HYOU

DVIOUT-HYOU () P. () AB () AB ³ ³, BA, BA ³ ³ P. A B B A IA (B B)A B (BA) B A ³, A ³ ³ B ³ ³ x z ³ A AA w ³ AA ³ x z ³ x + z +w ³ w x + z +w ½ x + ½ z +w x + z +w x,,z,w ³ A ³ AA I x,, z, w ³ A ³ ³ + + A ³ A A P.

More information

KEIRIN

KEIRIN KEIRIN KEIRIN PCOSS CIO PC PC OSS OSS 2003 CIO 2003 IT IT 2006 2006 IT IT IT IT 2008 2008 IT IT 2001 2001 5IT IT 5IT IT IT IT (NGN) Web2.0 (NGN) Web2.0 2005 IT CIO 2005 2005 IT CIO 2006 CIOIT IT SE 2006

More information

変 位 変位とは 物体中のある点が変形後に 別の点に異動したときの位置の変化で あり ベクトル量である 変位には 物体の変形の他に剛体運動 剛体変位 が含まれている 剛体変位 P(x, y, z) 平行移動と回転 P! (x + u, y + v, z + w) Q(x + d x, y + dy,

変 位 変位とは 物体中のある点が変形後に 別の点に異動したときの位置の変化で あり ベクトル量である 変位には 物体の変形の他に剛体運動 剛体変位 が含まれている 剛体変位 P(x, y, z) 平行移動と回転 P! (x + u, y + v, z + w) Q(x + d x, y + dy, 変 位 変位とは 物体中のある点が変形後に 別の点に異動したときの位置の変化で あり ベクトル量である 変位には 物体の変形の他に剛体運動 剛体変位 が含まれている 剛体変位 P(x, y, z) 平行移動と回転 P! (x + u, y + v, z + w) Q(x + d x, y + dy, z + dz) Q! (x + d x + u + du, y + dy + v + dv, z +

More information

2 1 1 α = a + bi(a, b R) α (conjugate) α = a bi α (absolute value) α = a 2 + b 2 α (norm) N(α) = a 2 + b 2 = αα = α 2 α (spure) (trace) 1 1. a R aα =

2 1 1 α = a + bi(a, b R) α (conjugate) α = a bi α (absolute value) α = a 2 + b 2 α (norm) N(α) = a 2 + b 2 = αα = α 2 α (spure) (trace) 1 1. a R aα = 1 1 α = a + bi(a, b R) α (conjugate) α = a bi α (absolute value) α = a + b α (norm) N(α) = a + b = αα = α α (spure) (trace) 1 1. a R aα = aα. α = α 3. α + β = α + β 4. αβ = αβ 5. β 0 6. α = α ( ) α = α

More information

SO(2)

SO(2) TOP URL http://amonphys.web.fc2.com/ 1 12 3 12.1.................................. 3 12.2.......................... 4 12.3............................. 5 12.4 SO(2).................................. 6

More information

x V x x V x, x V x = x + = x +(x+x )=(x +x)+x = +x = x x = x x = x =x =(+)x =x +x = x +x x = x ( )x = x =x =(+( ))x =x +( )x = x +( )x ( )x = x x x R

x V x x V x, x V x = x + = x +(x+x )=(x +x)+x = +x = x x = x x = x =x =(+)x =x +x = x +x x = x ( )x = x =x =(+( ))x =x +( )x = x +( )x ( )x = x x x R V (I) () (4) (II) () (4) V K vector space V vector K scalor K C K R (I) x, y V x + y V () (x + y)+z = x +(y + z) (2) x + y = y + x (3) V x V x + = x (4) x V x + x = x V x x (II) x V, α K αx V () (α + β)x

More information

医系の統計入門第 2 版 サンプルページ この本の定価 判型などは, 以下の URL からご覧いただけます. このサンプルページの内容は, 第 2 版 1 刷発行時のものです.

医系の統計入門第 2 版 サンプルページ この本の定価 判型などは, 以下の URL からご覧いただけます.   このサンプルページの内容は, 第 2 版 1 刷発行時のものです. 医系の統計入門第 2 版 サンプルページ この本の定価 判型などは, 以下の URL からご覧いただけます. http://www.morikita.co.jp/books/mid/009192 このサンプルページの内容は, 第 2 版 1 刷発行時のものです. i 2 t 1. 2. 3 2 3. 6 4. 7 5. n 2 ν 6. 2 7. 2003 ii 2 2013 10 iii 1987

More information

T1 T2 T3 T4 350 mm φ21 100 3.5 15wt% 0wt% 3.0 80 2.5 10wt% 60 2.0 5wt% 5wt% 40 1.5 1.0 10wt% 20 15wt% 0.5 0wt% 0 0.0 100 200 300 400 100 200 300 400 [μm] [μm] [%] [] = 0.9 = 0.5 = 0.1 ( =1.0) FDTD p/λ

More information

1.500 m X Y m m m m m m m m m m m m N/ N/ ( ) qa N/ N/ 2 2

1.500 m X Y m m m m m m m m m m m m N/ N/ ( ) qa N/ N/ 2 2 1.500 m X Y 0.200 m 0.200 m 0.200 m 0.200 m 0.200 m 0.000 m 1.200 m m 0.150 m 0.150 m m m 2 24.5 N/ 3 18.0 N/ 3 30.0 0.60 ( ) qa 50.79 N/ 2 0.0 N/ 2 20.000 20.000 15.000 15.000 X(m) Y(m) (kn/m 2 ) 10.000

More information

C10-075 26 2 12 1 1 4 1.1............................. 4 1.2............................ 5 1.3................................... 5 2 6 2.1............................ 6 2.2......................... 6

More information

untitled

untitled PGF 17 6 1 11 1 12 1 2 21 2 22 2 23 3 1 3 1 3 2 3 3 3 4 3 5 4 6 4 2 4 1 4 2 4 3 4 4 4 5 5 3 5 1 5 2 5 5 5 5 4 5 1 5 2 5 3 6 5 6 1 6 2 6 6 6 24 7 1 7 1 7 2 7 3 7 4 8 2 8 1 8 2 8 3 9 4 9 5 9 6 9 3 9 1 9

More information

MOS FET c /(17)

MOS FET c /(17) 1 -- 7 1 2008 9 MOS FT 1-1 1-2 1-3 1-4 c 2011 1/(17) 1 -- 7 -- 1 1--1 2008 9 1 1 1 1(a) VVS: Voltage ontrolled Voltage Source v in µ µ µ 1 µ 1 vin 1 + - v in 2 2 1 1 (a) VVS( ) (b) S( ) i in i in 2 2 1

More information

(Compton Scattering) Beaming 1 exp [i (k x ωt)] k λ k = 2π/λ ω = 2πν k = ω/c k x ωt ( ω ) k α c, k k x ωt η αβ k α x β diag( + ++) x β = (ct, x) O O x

(Compton Scattering) Beaming 1 exp [i (k x ωt)] k λ k = 2π/λ ω = 2πν k = ω/c k x ωt ( ω ) k α c, k k x ωt η αβ k α x β diag( + ++) x β = (ct, x) O O x Compton Scattering Beaming exp [i k x ωt] k λ k π/λ ω πν k ω/c k x ωt ω k α c, k k x ωt η αβ k α x β diag + ++ x β ct, x O O x O O v k α k α β, γ k γ k βk, k γ k + βk k γ k k, k γ k + βk 3 k k 4 k 3 k

More information

r d 2r d l d (a) (b) (c) 1: I(x,t) I(x+ x,t) I(0,t) I(l,t) V in V(x,t) V(x+ x,t) V(0,t) l V(l,t) 2: 0 x x+ x 3: V in 3 V in x V (x, t) I(x, t

r d 2r d l d (a) (b) (c) 1: I(x,t) I(x+ x,t) I(0,t) I(l,t) V in V(x,t) V(x+ x,t) V(0,t) l V(l,t) 2: 0 x x+ x 3: V in 3 V in x V (x, t) I(x, t 1 1 2 2 2r d 2r d l d (a) (b) (c) 1: I(x,t) I(x+ x,t) I(0,t) I(l,t) V in V(x,t) V(x+ x,t) V(0,t) l V(l,t) 2: 0 x x+ x 3: V in 3 V in x V (x, t) I(x, t) V (x, t) I(x, t) V in x t 3 4 1 L R 2 C G L 0 R 0

More information

TOP URL 1

TOP URL   1 TOP URL http://amonphys.web.fc.com/ 3.............................. 3.............................. 4.3 4................... 5.4........................ 6.5........................ 8.6...........................7

More information

ニトロトルエン

ニトロトルエン 4-115 116 4-3 2 117 4- g/kg/day mg/kg/day 25 125 30 40 50 100 250 300 ( ) ( ) ( ) ( ) F1 42 10 118 ER 10-11 M 1% 10-11 10-4 M ER 10-4 M 3% 10-11 10-4 M E-screen 10-9 10-4 M AR ( ) 10-6 10-4 M AR ( ) 10-6

More information